Patients who received MTX showed a trend for maintaining remission compared with those who did not receive MTX (Fig. 1 D and Table 1 ), although the differences were not statistically significant.
← all excerpts
Prediction of disease flare by biomarkers after discontinuing biologics in patients with rheumatoid arthritis achieving stringent remission.
1
—
—